LexDanaLexDanabeta
Inventor

STEVEN SHERIFF

Inventor
US

Overview

3→
Patents
2021–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07KPeptides30%
G01NInvestigating or analysing materials by determining their chemical or physical properties10%
PatentTitleYear
12,065,505Antibodies and antigen binding peptides for factor XIa inhibitors and uses thereof202411,708,405IP-10 antibodies and their uses202311,136,406Methods of treating immune diseases by administering antibody polypeptides that antagonize CD402021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2024Patents assigned to BRISTOL MYERS SQUIBB CO (3)· patent assignee history
2021Patents assigned to DOMANTIS LTD (1)· patent assignee history
2021–2024Based in US· patent location history
2023Patents assigned to BRISTOL MYERS QUIBB COMPANY (1)· patent assignee history
2024Patents assigned to JANSSEN PHARMACEUTICALS INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BRISTOL MYERS SQUIBB CO32021–2024
BRISTOL MYERS QUIBB COMPANY12023
DOMANTIS LTD12021
JANSSEN PHARMACEUTICALS INC12024
Locations
LocationPatentsSpan
US32021–2024